Publication:
Efficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients with Non Alcoholic Fatty Liver ID 2155869

Simple item page
dc.contributor.authorVenkatarayana, Gangarapu
dc.contributor.authorİNCE, ALİ TÜZÜN
dc.contributor.authorBAYSAL, BİROL
dc.contributor.authorKAYAR, YUSUF
dc.contributor.authorHakan, Şentürk
dc.contributor.authorKILIÇ, ÜLKAN
dc.contributor.authorGÖK, ÖZLEM
dc.contributor.authorUYSAL, ÖMER
dc.contributor.institutionauthorİNCE, ALİ TÜZÜN
dc.contributor.institutionauthorŞENTÜRK, HAKAN
dc.contributor.institutionauthorUYSAL, ÖMER
dc.date.accessioned2020-01-16T21:00:39Z
dc.date.available2020-01-16T21:00:39Z
dc.date.issued2015-05-15T00:00:00Z
dc.identifier.citationVenkatarayana G., İNCE A. T. , BAYSAL B., KAYAR Y., Hakan Ş., KILIÇ Ü., GÖK Ö., UYSAL Ö., -Efficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients with Non Alcoholic Fatty Liver ID 2155869-, Digestive Diseases Week 2015, Washington, Kiribati, 15 - 19 Mayıs 2015
dc.identifier.urihttps://openaccess.bezmialem.edu.tr/handle/20.500.12645/13337
dc.identifier.yoksis1511515
dc.titleEfficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients with Non Alcoholic Fatty Liver ID 2155869
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.idd02b2534-bfcb-4efe-8434-9055b8188aad
local.publication.isinternational1
relation.isAuthorOfPublication6daa6ab7-ee45-4f50-9e71-e831046b6462
relation.isAuthorOfPublication278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isAuthorOfPublication19df24c5-c3e8-4158-8eed-717f885c608d
relation.isAuthorOfPublication.latestForDiscovery278fcf63-3b92-4368-bff6-f140ebd9aeb3
Files
Collections
Yayınlar - Eserler